Free Trial

Cellebrite DI (CLBT) News Today

Cellebrite DI logo
$20.61 +0.73 (+3.67%)
Closing price 04:00 PM Eastern
Extended Trading
$20.51 -0.10 (-0.49%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Cellebrite DI Ltd. stock logo
Quantbot Technologies LP Sells 29,868 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)
Quantbot Technologies LP lessened its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 26.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 84,450 shares of the company's stock after se
Cellebrite DI Ltd. stock logo
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Increases Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)
Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 9.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 190,012
Cellebrite DI Ltd. stock logo
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of "Buy" from Brokerages
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) have been given an average recommendation of "Buy" by the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average twelve-mont
Cellebrite DI Ltd. stock logo
453,700 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. bought a new stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 453,700 shares of the company's stock, valued at approximately $9,995,000. Raymond
Cellebrite DI Ltd. stock logo
Cellebrite DI Ltd. (NASDAQ:CLBT) Sees Significant Growth in Short Interest
Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 1,070,000 shares, a growth of 17.6% from the February 13th total of 909,700 shares. Approximately 1.4% of the shares of the company are short sold. Based on an average daily trading volume, of 1,790,000 shares, the short-interest ratio is presently 0.6 days.
Cellebrite DI Ltd. stock logo
Royce & Associates LP Sells 398,303 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)
Royce & Associates LP decreased its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 56.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 312,184 shares of the company's stock after selling 398,303 shares during the period. Royce & As
Cellebrite files 2024 Annual Report on Form 20-F
Cellebrite Files its 2024 Annual Report on Form 20-F
Cellebrite DI Ltd. stock logo
Connor Clark & Lunn Investment Management Ltd. Cuts Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)
Connor Clark & Lunn Investment Management Ltd. decreased its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 21.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor ow
Cellebrite DI Ltd. stock logo
Telemark Asset Management LLC Increases Position in Cellebrite DI Ltd. (NASDAQ:CLBT)
Telemark Asset Management LLC lifted its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 25.0% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 500,000 shares of the company's stock after buying an additio
Cellebrite DI Ltd. stock logo
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD Has $22.37 Million Stock Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD cut its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 33.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,016,028 sha
Cellebrite DI Ltd. stock logo
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Decreases Stock Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD trimmed its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 33.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 348,173 shares of the compan
Cellebrite DI (CLBT) Gets a Buy from Lake Street
Craig-Hallum Sticks to Its Buy Rating for Cellebrite DI (CLBT)
Cellebrite DI Ltd. stock logo
Cellebrite DI (NASDAQ:CLBT) Earns "Buy" Rating from Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and issued a $28.00 price objective on shares of Cellebrite DI in a research note on Monday.
Cellebrite DI Ltd. stock logo
365,833 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Bought by Bank Julius Baer & Co. Ltd Zurich
Bank Julius Baer & Co. Ltd Zurich bought a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 365,833 shares of the company's stock, valued at approximately $8,126,000.
Cellebrite management to meet with Lake Street
Cellebrite DI Ltd. stock logo
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Bought by True Wind Capital Management L.P.
True Wind Capital Management L.P. lifted its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,861,007 shares of the company's stock after buying an a
Cellebrite DI Ltd. stock logo
Clal Insurance Enterprises Holdings Ltd Sells 469,838 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)
Clal Insurance Enterprises Holdings Ltd lowered its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,496,109 shares of
Cellebrite management to meet with Needham
Cellebrite management to meet with Craig-Hallum
Cellebrite DI Ltd. stock logo
ARK Investment Management LLC Reduces Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
ARK Investment Management LLC reduced its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 38.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,823 shares of the company's stock afte
Cellebrite DI Ltd. stock logo
Handelsbanken Fonder AB Invests $3.94 Million in Cellebrite DI Ltd. (NASDAQ:CLBT)
Handelsbanken Fonder AB acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 178,700 shares of the company's stock, valued at approximately $3,937,
Cellebrite DI Ltd. stock logo
Principal Financial Group Inc. Has $23.24 Million Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Principal Financial Group Inc. cut its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 24.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,054,988 shares of the company's sto
Cellebrite DI Ltd. stock logo
28,988 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Bought by Van ECK Associates Corp
Van ECK Associates Corp acquired a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 28,988 shares of the company's stock, valued at approximat
Cellebrite DI Ltd. stock logo
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Sold by Meitav Investment House Ltd.
Meitav Investment House Ltd. cut its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 33.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,370,855 shares of the company's stock after selling
Cellebrite DI Ltd. stock logo
Cellebrite DI Ltd. (NASDAQ:CLBT) is Pembroke Management LTD's 2nd Largest Position
Pembroke Management LTD increased its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 4.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,992,432 shares of the company's stock after buyi
Cellebrite DI Ltd. stock logo
Blue Trust Inc. Makes New $468,000 Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)
Blue Trust Inc. purchased a new stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 21,226 shares of the company's stock
Cellebrite DI Ltd. stock logo
Lake Street Capital Issues Positive Forecast for Cellebrite DI (NASDAQ:CLBT) Stock Price
Lake Street Capital increased their target price on shares of Cellebrite DI from $17.00 to $26.00 and gave the stock a "buy" rating in a report on Friday.
Cellebrite DI Ltd. stock logo
Needham & Company LLC Reaffirms "Buy" Rating for Cellebrite DI (NASDAQ:CLBT)
Needham & Company LLC restated a "buy" rating and set a $28.00 price target on shares of Cellebrite DI in a research report on Friday.
Cellebrite price target raised to $30 from $25 at TD Cowen
Cellebrite price target raised to $27 from $24 at Deutsche Bank
Cellebrite reports Q4 EPS 10c, consensus 10c
Cellebrite DI Ltd. stock logo
Cellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Misses Expectations By $0.03 EPS
Cellebrite DI (NASDAQ:CLBT - Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%.
Cellebrite DI Ltd. stock logo
Cellebrite DI (NASDAQ:CLBT) Trading Down 7.2% on Disappointing Earnings
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 7.2% After Earnings Miss
Cellebrite DI Ltd. stock logo
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Cellebrite DI (NASDAQ:CLBT) Stock
JPMorgan Chase & Co. increased their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the company an "overweight" rating in a research report on Tuesday.
Remove Ads
Get Cellebrite DI News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter.

CLBT Media Mentions By Week

CLBT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLBT
News Sentiment

1.02

0.72

Average
Business Services
News Sentiment

CLBT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLBT Articles
This Week

9

5

CLBT Articles
Average Week

Remove Ads
Get Cellebrite DI News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CLBT) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners